Login to Your Account



ASCO 2013

Nanobiotix Nanoparticle Targets Radiotherapy Effects on Tumors

By Nuala Moran
Staff Writer

Friday, May 31, 2013
in_the_clinic.jpg

LONDON – Nanobiotix SA presented positive safety data from the first clinical study of NBTXR3, a nanoparticle drug that enhances the effects of radiotherapy on tumor cells without damaging healthy tissue, at ASCO on Saturday.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription